Genetic Testing Startup 23andMe CEO Says Company Didn't 'Communicate Proactively' With The FDA

Advertisement

Anne Wojcicki and sergey brin at fashion show

REUTERS/Carlo Allegri

23andMe CEO Anne Wojcicki

23andMe CEO Anne Wojcicki said in a recent interview with Fortune that her DNA testing startup did not "communicate proactively" with the Food and Drug Administration.

Advertisement

About a week ago, the FDA sent a warning letter to 23andMe, telling the startup to stop marketing its DNA testing kits.

Wojcicki has been relatively quiet until now.

Complimentary Tech Event
Transform talent with learning that works
Capability development is critical for businesses who want to push the envelope of innovation.Discover how business leaders are strategizing around building talent capabilities and empowering employee transformation.Know More

"We want to work with them and we will work with them," Wojcicki told an audience at a Fortune Most Powerful Women event last night. "I can't say much [more] because we're actively engaged in what is the next step forward."

You can check out the full interview on Fortune.

Advertisement